Kwame Ulmer is the Managing Partner at MedTech Impact Partners – A Regulatory Strategy Consulting Firm. Kwame brings twenty years of experience evaluating medical technologies in the government and private sector, and serving in senior operating roles at medical device companies to help companies successfully engage the FDA. He has personally evaluated more than 1,000 medical technologies in his career. Kwame spent 12 years at the FDA in progressive leadership roles. He also served as Vice President, Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company. He is also a venture partner at Wavemaker Three-Sixty Health – the leading Southern-California based, early stage venture capital firm (Seed and Series A) focused on the healthcare industry. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation and advising portfolio company management teams). Kwame sits on the board and advises several privately held medtech companies. Kwame serves on the board of the University of Virginia Licensing and Ventures Group and California Life Sciences. He is also a lecturer and researcher in medtech innovation at the University of California, Los Angeles. Kwame founded MedTech Color, a nonprofit with a mission to advance the representation of persons of color in the medical device industry. He earned his B.S. in Physics from Lincoln University, and has two Masters degrees from the University of Virginia, in Materials Engineering and Business Administration.